Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
P/B ratio for Inogen, Inc. (INGN)
P/B ratio as of 2023: 0.62
According to Inogen, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.62. At the end of 2022 the company had a P/B ratio of 1.51.
P/B ratio history for Inogen, Inc. from 2011 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 0.62 |
| 2022 | 1.51 |
| 2021 | 2.07 |
| 2020 | 2.81 |
| 2019 | 4.33 |
| 2018 | 9.01 |
| 2017 | 10.85 |
| 2016 | 7.40 |
| 2015 | 5.80 |
| 2014 | 4.30 |
| 2013 | 4.86 |
| 2012 | 7.70 |
| 2011 | 29.11 |